| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.074 | 0.1 |